Morning Brief: Long COVID In Kids, Whistleblower Lawsuit, And The Valley

Österreich Nachrichten Nachrichten

Morning Brief: Long COVID In Kids, Whistleblower Lawsuit, And The Valley
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 LAist
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Good morning, L.A. ☀️ Here's what you need to know today.

By this point, most of us are likely familiar with the common symptoms of COVID-19: dry cough, fever, difficulty breathing in more severe cases.

My colleague Jackie Fortiér, who has been reporting on the pandemic since its onset in 2020, writes thatestimated 10% to 20% of that groupOne major difference between long COVID in adults and in children is that young people often don’t develop symptoms upon their initial infection. So if long COVID does strike, it’s not top of mind for pediatricians.It may seem, then, that they “have symptoms for which there is no clear cause,” said Dr.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

LAist /  🏆 606. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

What Everyone Should Understand About Brain FogWhat Everyone Should Understand About Brain FogWhile it may not be possible to cure brain fog, these strategies can help people manage it better
Weiterlesen »

FDA approves Remdesivir to treat COVID in young childrenFDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Weiterlesen »

COVID antiviral approved for young kids but vaccine still not availableCOVID antiviral approved for young kids but vaccine still not availableNearly 1,700 parents and doctors across the country have filed a Citizen Petition calling on the FDA to approve a COVID vaccine for kids under 5. The petition comes on the same day the FDA announced the approval of the antiviral drug remdesivir to treat COVID patients as young as 28 days and weighing about 7 pounds.
Weiterlesen »

FDA approves Remdesivir to treat COVID in young childrenFDA approves Remdesivir to treat COVID in young childrenThe antiviral drug is given as an injection. It was previously approved for patients 12 years of age and older.
Weiterlesen »

FDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsFDA approves COVID drug for children, China deals with uphill COVID battle, and more COVID newsThe US Food and Drug Administration announced Monday that it has expanded approval of the COVID-19 drug remdesivir to treat patients as young as 28 days old. Here's that and more COVID news.
Weiterlesen »

One Grim Statistic Lays Bare The Truly Relentless Grip of Long COVIDOne Grim Statistic Lays Bare The Truly Relentless Grip of Long COVIDNot even one in four people have completely recovered from COVID a full year after being hospitalized with the disease, a UK study indicated Sunday, warning that long COVID could become a common condition.
Weiterlesen »



Render Time: 2025-04-07 06:12:04